Trade Summary

5 days ago, Delaet Ingrid, serving as Chief Regulatory Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 4,367 shares at $181.02 per share, for a total transaction value of $790,514.34. Following this transaction, Delaet Ingrid now holds 16,225 shares of NBIX.

This sale represents a 21.21% decrease in Delaet Ingrid's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, July 10, 2026 and publicly disclosed via SEC Form 4 filing on Monday, July 13, 2026 at 4:27 PM ET, 3 days after the trade was made.

NEUROCRINE BIOSCIENCES INC operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.